Geode Capital Management, LLC 180 Life Sciences Corp. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.81 - $2.53 $4,894 - $15,288	6,043 Added 2.93%	212,464 $180,000
Q1 2022 May 13, 2022	BUY	$2.53 - $3.9 $11,326 - $17,460	4,477 Added 2.22%	206,421 $534,000
Q4 2021 Feb 11, 2022	BUY	$3.27 - $6.38 $239,432 - $467,149	73,221 Added 56.88%	201,944 $787,000
Q3 2021 Nov 12, 2021	BUY	$5.11 - $10.81 $28,994 - $61,335	5,674 Added 4.61%	128,723 $696,000
Q2 2021 Aug 13, 2021	SELL	$6.7 - $11.98 $51,228 - $91,599	-7,646 Reduced 5.85%	123,049 $1.23 Million
Q1 2021 May 12, 2021	BUY	$2.51 - $6.96 $328,044 - $909,637	130,695 New	130,695 $857,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $81.1M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.